News
TCRT
2.640
-2.94%
-0.080
Weekly Report: what happened at TCRT last week (0202-0206)?
Weekly Report · 3d ago
Weekly Report: what happened at TCRT last week (0126-0130)?
Weekly Report · 02/02 10:31
Weekly Report: what happened at TCRT last week (0119-0123)?
Weekly Report · 01/26 10:31
Weekly Report: what happened at TCRT last week (0112-0116)?
Weekly Report · 01/19 10:38
Weekly Report: what happened at TCRT last week (0105-0109)?
Weekly Report · 01/12 10:37
Alaunos Updates Governance, Ends Cantor Advisory Agreement
TipRanks · 01/08 13:58
ALAUNOS THERAPEUTICS INC - TERMINATES ENGAGEMENT WITH CANTOR FITZGERALD - SEC FILING
Reuters · 01/08 13:31
Weekly Report: what happened at TCRT last week (1229-0102)?
Weekly Report · 01/05 10:30
Weekly Report: what happened at TCRT last week (1222-1226)?
Weekly Report · 12/29/2025 10:29
Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer
TipRanks · 12/23/2025 22:54
Alaunos Therapeutics Settles Outstanding Invoices with MD Anderson for $285,055
Reuters · 12/23/2025 22:19
Weekly Report: what happened at TCRT last week (1215-1219)?
Weekly Report · 12/22/2025 10:29
Weekly Report: what happened at TCRT last week (1208-1212)?
Weekly Report · 12/15/2025 10:37
Weekly Report: what happened at TCRT last week (1201-1205)?
Weekly Report · 12/08/2025 10:36
Weekly Report: what happened at TCRT last week (1124-1128)?
Weekly Report · 12/01/2025 10:31
Weekly Report: what happened at TCRT last week (1117-1121)?
Weekly Report · 11/24/2025 10:36
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 11/17/2025 12:06
Weekly Report: what happened at TCRT last week (1110-1114)?
Weekly Report · 11/17/2025 10:37
Ziopharm: Q3 Earnings Snapshot
Barchart · 11/14/2025 15:31
Weekly Report: what happened at TCRT last week (1103-1107)?
Weekly Report · 11/10/2025 10:34
More
Webull provides a variety of real-time TCRT stock news. You can receive the latest news about Alaunos Therapeutics, Inc through multiple platforms. This information may help you make smarter investment decisions.
About TCRT
Alaunos Therapeutics, Inc. is a pre-clinical obesity and metabolic disorder and clinical-stage oncology-focused cell therapy company. The Company focuses on developing small molecules that are expected to be efficacious against obesity and other metabolic disorders. The Company is engaged in developing novel small molecule-based obesity therapeutics. The Company’s operations consist primarily of conducting research and development and raising capital to fund those efforts. The Company has not generated any revenues.